Growth Metrics

Nexalin Technology (NXL) EPS (Weighted Average and Diluted) (2022 - 2026)

Nexalin Technology has reported EPS (Weighted Average and Diluted) over the past 4 years, most recently at -$0.13 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 53.57% year-over-year to -$0.13; the TTM value through Dec 2025 reached -$0.51, up 37.8%, while the annual FY2025 figure was -$0.5, 39.76% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.13 at Nexalin Technology, roughly flat from -$0.13 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at -$0.03 in Q3 2022 and troughed at -$0.31 in Q3 2023.
  • A 4-year average of -$0.15 and a median of -$0.13 in 2025 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 933.33% in 2023 and later surged 53.57% in 2025.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.11 in 2022, then rose by 9.09% to -$0.1 in 2023, then tumbled by 180.0% to -$0.28 in 2024, then surged by 53.57% to -$0.13 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for NXL at -$0.13 in Q4 2025, -$0.13 in Q3 2025, and -$0.1 in Q2 2025.